An African perspective on mucosal immunity and HIV-1 - PubMed (original) (raw)
Review
doi: 10.1038/mi.2009.23. Epub 2009 May 6.
Affiliations
- PMID: 19421180
- DOI: 10.1038/mi.2009.23
Free article
Review
An African perspective on mucosal immunity and HIV-1
P Pala et al. Mucosal Immunol. 2009 Jul.
Free article
Abstract
HIV prevention mandates an understanding of the mechanisms of mucosal immunity with attention to some unique features of the epidemic and mucosal environment in the developing world. An effective vaccine will have to induce mucosal protection against a highly diverse virus, which is equipped with a number of immune evasion strategies. Its development will require assessment of mucosal immune responses, and it will have to protect a mucosal environment where inflammation and altered immune responses are common because of the presence of other mucosal infections, such as sexually transmitted infections and parasites, and where nutritional status may also be compromised. Ideally, not only prevention methods would protect adults but also provide cover against gastrointestinal transmission through maternal milk. Prevention might also be complemented by microbicides and circumcision, two alternative approaches to mucosal protection. It seems unlikely that a single solution will work in all instances and intervention might have to act at multiple levels and be tailored to local circumstances. We review here some of the mucosal events associated with HIV infection that are most relevant in an African setting.
Comment in
- Mucosal immunology in low- and middle-income countries.
Garside P. Garside P. Mucosal Immunol. 2009 Jul;2(4):279. doi: 10.1038/mi.2009.18. Mucosal Immunol. 2009. PMID: 19532119 No abstract available.
Similar articles
- Simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective HIV-1 vaccines.
Belyakov IM, Ahlers JD. Belyakov IM, et al. Curr Med Chem. 2011;18(26):3953-62. doi: 10.2174/092986711796957293. Curr Med Chem. 2011. PMID: 21824096 - Mucosal immunity and HIV-1 infection: applications for mucosal AIDS vaccine development.
Belyakov IM, Ahlers JD. Belyakov IM, et al. Curr Top Microbiol Immunol. 2012;354:157-79. doi: 10.1007/82_2010_119. Curr Top Microbiol Immunol. 2012. PMID: 21203884 Review. - Innate gamma/delta T-cells during HIV infection: Terra relatively Incognita in novel vaccination strategies?
Agrati C, D'Offizi G, Gougeon ML, Malkovsky M, Sacchi A, Casetti R, Bordoni V, Cimini E, Martini F. Agrati C, et al. AIDS Rev. 2011 Jan-Mar;13(1):3-12. AIDS Rev. 2011. PMID: 21412385 Review. - Mucosal Vaccination for Prevention of HIV Infection and AIDS.
Aldovini A. Aldovini A. Curr HIV Res. 2016;14(3):247-59. doi: 10.2174/1570162x14999160224103025. Curr HIV Res. 2016. PMID: 26957199 Review.
Cited by
- The Importance of Regulation in Natural Immunity to HIV.
Blondin-Ladrie L, Aranguren M, Doyon-Laliberté K, Poudrier J, Roger M. Blondin-Ladrie L, et al. Vaccines (Basel). 2021 Mar 18;9(3):271. doi: 10.3390/vaccines9030271. Vaccines (Basel). 2021. PMID: 33803543 Free PMC article. Review. - Highly-Exposed HIV-1 seronegative Female Commercial Sex Workers sustain in their genital mucosa increased frequencies of tolerogenic myeloid and regulatory T-cells.
Thibodeau V, Fourcade L, Labbé AC, Alary M, Guédou F, Poudrier J, Roger M. Thibodeau V, et al. Sci Rep. 2017 Mar 6;7:43857. doi: 10.1038/srep43857. Sci Rep. 2017. PMID: 28262752 Free PMC article. - Schistosoma mansoni Infection in Ugandan Men Is Associated with Increased Abundance and Function of HIV Target Cells in Blood, but Not the Foreskin: A Cross-sectional Study.
Prodger JL, Ssemaganda A, Ssetaala A, Kitandwe PK, Muyanja E, Mpendo J, Nanvubya A, Wambuzi M, Nielsen L, Kiwanuka N, Kaul R. Prodger JL, et al. PLoS Negl Trop Dis. 2015 Sep 3;9(9):e0004067. doi: 10.1371/journal.pntd.0004067. eCollection 2015. PLoS Negl Trop Dis. 2015. PMID: 26335139 Free PMC article. - Cross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.
Kyongo JK, Crucitti T, Menten J, Hardy L, Cools P, Michiels J, Delany-Moretlwe S, Mwaura M, Ndayisaba G, Joseph S, Fichorova R, van de Wijgert J, Vanham G, Ariën KK, Jespers V. Kyongo JK, et al. Clin Vaccine Immunol. 2015 May;22(5):526-38. doi: 10.1128/CVI.00762-14. Epub 2015 Mar 11. Clin Vaccine Immunol. 2015. PMID: 25761460 Free PMC article. - Natural Immunity to HIV: a delicate balance between strength and control.
Poudrier J, Thibodeau V, Roger M. Poudrier J, et al. Clin Dev Immunol. 2012;2012:875821. doi: 10.1155/2012/875821. Epub 2012 Dec 11. Clin Dev Immunol. 2012. PMID: 23304192 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical